Sulindac Tablet
Product Images NDC 24658-770

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 24658-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Laboratories Llc Dba Blu Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula

This is a mathematical expression that represents negative 25.*

FDA Label Image

Sulindac 150mg 100ct

This is a medication description for Sulindac Tablets, 150mg, with a usual dosage that can be found in accompanying literature for complete prescribing information. The tablets are dispensed with a medication guide, and must be stored at a controlled room temperature between 20°C and 25°C. The medication should be kept out of the reach of children, and distributed in a tightly closed and light-resistant container with a child-resistant closure. The medication is distributed by PuraCap Lavoratories, LLC, doing business as Blu Pharmaceuticals in Franklin, KY, USA.*

FDA Label Image

Sulindac 200mg 500ct

This is the text found on a bottle of Sulindac tablets, USP by Blu Pharmaceuticals. Each tablet contains 20mg of Sulindac USP, with 500 tablets in the bottle. Complete prescribing information can be found in accompanying literature. The medication should be stored at 20-25°C and dispensed in a tightly closed container with a child-resistant closure. It is important to keep this and all medications out of reach of children. The medication is distributed by PuraCap Laboratories LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.